-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
FibroBiologics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2024.
- FibroBiologics, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$4.49M, a 39.3% decline year-over-year.
- FibroBiologics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$16.1M, a 43.5% decline year-over-year.
- FibroBiologics, Inc. annual Operating Income (Loss) for 2024 was -$13.7M, a 54.5% decline from 2023.
- FibroBiologics, Inc. annual Operating Income (Loss) for 2023 was -$8.89M, a 99% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)